Economy/Home · Economy

HLB Shares Weak in 40,000-Won Range... 6 of 8 HLB Group Stocks Fall, HLB Biostep Rises Over 2%

On the morning of the 23rd, six of eight HLB Group-related stocks fell in the domestic stock market, with weakness prevailing overall. While most affiliates including HLB Life Science, HLB Panzinc, HLB Pharmaceutical, HLB Global, and HLB Innovation declined, only HLB Biostep and HLB Therapeutics ros

Wooil Shim
Staff Reporter
8 min read
HLB Shares Weak in 40,000-Won Range... 6 of 8 HLB Group Stocks Fall, HLB Biostep Rises Over 2%
CBC News

On the morning of the 23rd, six of eight HLB Group-related stocks fell in the domestic stock market, with weakness prevailing overall. While most affiliates including HLB Life Science, HLB Panzinc, HLB Pharmaceutical, HLB Global, and HLB Innovation declined, only HLB Biostep and HLB Therapeutics rose, showing mixed movements across the stocks.

HLB Weak in the 40,000-Won Range... Rose to 41,650 Won Intraday Before Pulling Back

HLB (028300) is trading at 40,850 won, down 450 won (1.09%) from the previous session. Starting the day at 40,700 won, HLB rose to 41,650 won intraday before falling to 41,000 won, repeatedly fluctuating. The gap between the intraday high and low is 1,550 won. The current price is 750 won above the intraday low but has not reached the previous day's close of 41,300 won. Trading volume was recorded at 334,334 shares.

HLB Panzinc and HLB Life Science Down Over 2%... Among the Biggest Decliners

HLB Panzinc posted the largest decline among the group-related stocks. Its share price is 1,361 won, down 33 won (2.37%) from the previous session. It opened at 1,381 won and rose to 1,399 won intraday before falling to 1,315 won. Trading volume was 88,585 shares.

HLB Life Science is trading at 3,425 won, down 80 won (2.28%) from the previous session. It opened at 3,485 won, rose to 3,505 won intraday, and then fell to 3,305 won. Trading volume was 226,831 shares.

HLB Global is trading at 1,894 won, down 22 won (1.15%) from the previous session. Its intraday high was 1,957 won and its low was 1,870 won, with a trading volume of 151,517 shares.

HLB Pharmaceutical is trading at 10,040 won, down 110 won (1.08%). It opened at 10,150 won and rose to 10,170 won intraday before falling to 9,790 won. The current price remains in the 10,000-won range, and its trading volume of 343,548 shares is the largest among the group-related stocks.

HLB Innovation recorded 15,740 won, down 140 won (0.88%) from the previous session. It rose to 16,190 won intraday before falling to 15,000 won, with a trading volume of 53,123 shares.

HLB Biostep Up 2.43%... HLB Therapeutics Also Rises

HLB Biostep recorded the highest gain among the group-related stocks. Its share price is trading at 5,900 won, up 140 won (2.43%) from the previous session. Opening at 5,600 won, it rose to 6,050 won intraday before falling to 5,310 won, then climbed back to 5,900 won. Trading volume was 296,005 shares.

HLB Therapeutics also trended upward. Its share price is 2,695 won, up 25 won (0.94%) from the previous session. It opened at 2,670 won and rose to 2,710 won intraday, with a low of 2,600 won. Trading volume was 267,533 shares.

HLB Pharmaceutical Has the Highest Volume... Cause of Price Movements Unconfirmed

The largest decline of the day was HLB Panzinc (2.37%), followed by HLB Life Science (2.28%). HLB Global, HLB, and HLB Pharmaceutical each fell in the 1% range, while HLB Innovation fell only 0.88%, showing a relatively small drop. Notably, HLB Biostep moved between 5,310 and 6,050 won intraday, showing a relatively wide price fluctuation.

In terms of trading volume, HLB Pharmaceutical had the most at 343,548 shares, followed by HLB at 334,334 shares. HLB Biostep (296,005 shares) and HLB Therapeutics (267,533 shares) came next.

However, the specific cause of the price movements in HLB Group-related stocks on this day has not been confirmed. As it is also unclear whether individual companies' business issues or clinical trial progress directly affected the day's share prices, it is difficult to attribute a specific cause based on price fluctuations alone.

[This article is provided for informational purposes to aid investment decisions and does not recommend the purchase or sale of any specific stock. Content may vary depending on market conditions. Investment decisions and any resulting responsibility rest with the investor. AI provided partial assistance.]

Wooil Shim
Staff Reporter

CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.